India, Oct. 20 -- As the global healthcare industry sprints toward smarter, personalised innovation, new technologies are reshaping pharma at an unprecedented pace. The healthcare AI opportunity alone is projected to touch nearly USD 350-410 billion by 2025, with applications across drug discovery, clinical trials, precision medicine, and operations.

Meanwhile, the market for digital twins-virtual replicas of plants, patients, and processes-is accelerating rapidly, set to expand from USD 1.4 billion in 2025 to nearly USD 6.8 billion by 2032, at a CAGR of 25.7 percent.

Against this backdrop, Braj Panda, Head of Digital, Dr. Reddy's, discusses how generics pharma is evolving from Industry 4.0 efficiencies to an Industry 5.0 reality-where ...